Following several years research into the new and exciting advancement in the emerging nanotechnology industry, Healthy Channels Pty Ltd was established to bring some of this technology to the general public. One specific technology, known as Silversure, utilises the latest advances in Silver Nanotechnology Antimicrobial Protection.
Anteo Diagnostics specialises in the development and commercialisation of proprietary surface coatings for applications in the diagnostics and biotech industries. With Mix&Go we have developed “molecular glues” which are used by our partners and customers to immobilize delicate biological molecules such as antibodies to synthetic surfaces.
ATA Scientific specialises in marketing and servicing analytical and scientific instruments with a products focus on the Particle Sciences, Biotechnology and Spectroscopy. They include instruments applicable to nano particle, micro emulsion and bio-surface research.
Biometic develops & manufactures bioactive scaffold systems for tissue engineering and bioreactor culture. These are optimized for a range of soft and hard tissue applications. As part of an ongoing collaborative and interdisciplinary development program, Biometic is helping advance fundamental understanding in tissue culture, biomechanics and medical research.
Biomimetics Pty Ltd has developed an innovative enabling technology to coat bone-like nanohydroxyapatite for the production of an unique synthetic bone graft material that has increased superiority in bioactivity, strength controlled solubility and drug delivery over similiar products already in the market. It is a platform technology with a wide range of applications.
Evolved from more than 15 years research at Sydney's Macquarie University, BluGlass has invented a novel process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN), crucial to the production of high efficiency devices including next generation lighting technology Light Emitting Diodes (LEDs) at a fraction of the current cost.
Bridge8 advises small and medium size organisations where creating vision and making connections between organisations and their communities is vital to success. Bridge8 brings specific capabilities in foresight and strategy facilitation and development, and marketing and communications for science and technology.
Commercializes a nano and micron sized ceramic spheres technology that provides encapsulation and controlled release of active molecules for a variety of applications including drug delivery, cosmeceuticals and speciality chemicals.